Abstract. accumulating evidence has proved that potassium channels (K + channels) are involved in regulating cell proliferation, cell cycle progression and apoptosis of tumor cells. However, the precise cellular mechanisms are still unknown. in the present study, we investigated the effect and mechanisms of quinidine, a commonly used voltage-gated K + channel blocker, on cell proliferation and apoptosis of human glioma U87-MG cells. We found that quinidine significantly inhibited the proliferation of u87-Mg cells and induced apoptosis in a dose-dependent manner. the results of caspase colorimetric assay showed that the mitochondrial pathway was the main mode involved in the quinidine-induced apoptotic process. furthermore, the concentration range of quinidine, which inhibited voltage-gated K + channel currents in electrophysiological assay, was consistent with that of quinidine inhibiting cell proliferation and inducing cell apoptosis. in u87-Mg cells treated with quinidine (100 µmol/l), 11 of 2,042 human micrornas (mirnas) were upregulated and 16 were downregulated as detected with the mirna array analysis. the upregulation of mir-149-3p and downregulation of mir-424-5p by quinidine treatment were further verified by using quantitative real-time PCR. In addition, using mirna target prediction program, putative target genes related to cell prolif eration and apoptosis for two differentially expressed mirnas were predicted. taken together, these data suggested that the anti-proliferative and pro-apoptosis effect of voltage-gated K + channel blocker quinidine in human glioma cells was mediated at least partly through regulating expression of mirnas, and provided further support for the mechanisms of voltage-gated K + channels in mediating cell proliferation and apoptosis.
Introduction
Potassium channels (K + channels) are the most diverse ion channels on the plasma membrane of mammalian cells (1) . accumulating evidence has proved that a variety of K + channels, including voltage-gated (2), calcium-activated (3), two-pore domain (4) and inward rectifier (5) K + channels are overexpressed in tumorous tissues compared to their healthy counterparts. they control the membrane potential as well as electrical signaling and are known to be involved in the regulation of proliferation, cell cycle progression and apoptosis of tumor cells (6) .
among all the K + channels mentioned, most studies are directed at examining the impact of voltage-gated K + channels on the proliferation of tumor cells (1) . Voltage-gated K + channel blockers, such as 4-aminopyridine, and tetraethylammonium, have been shown to inhibit cell proliferation and growth of tumor via an arrest in the g 0 /g 1 transition during the cell cycle (7) . Quinidine, another commonly used voltage-gated K + channel blocker, can reduce the proliferation of tumor cells, such as human malignant mesothelioma cells and rat c6 glioma cells (8, 9) . However, the precise cellular mechanisms by which voltage-gated K + channel activity contributes to cell proliferation and apoptosis are not clear yet.
Micrornas (mirnas) are small non-coding rnas that regulate gene expression through degradation of mrna or translational inhibition of target mrna (10) . mirnas act as key mediators in the progression and transformation of tumor through their regulation of proliferation, differentiation, and apoptosis (11) . While many aspects of mirna-induced protein regulation are known, there is a growing need to uncover the complex regulatory mechanisms governing the activation and suppression of mirna expression (12) . interestingly, alterations in expression and function of ion channels/transporters have been shown to result in changes in expression of mirnas (13 (14) . mir-21 and -30a, both of which are implicated in cancer development (15, 16) , are regulated by l-type ca 2+ channels (17) . However, there is scarce literature on the effect of voltage-gated K + channels on mirna expression.
in this study, we investigated the effect of quinidine on cell proliferation, apoptosis and expression of mirnas of human glioma cell line u87-Mg, and tried to find out whether quinidine affects cell proliferation and apoptosis by regulating mirna expression. the results showed that the anti-proliferative and pro-apoptosis effect of quinidine in human glioma cells was mediated at least partly through regulating expression of mirnas and provided further support for the mechanisms of voltage-gated K + channels in mediating cell proliferation and apoptosis.
Materials and methods
Reagents. Quinidine, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Mtt) and tetrodotoxin (ttX) were products of the Sigma-aldrich corp. (St. louis, Mo, USA). RPMi-1640 medium and fetal bovine serum (fBS) were obtained from life technologies (carlsbad, ca, uSa). annexin V-fuorescein isothiocyanate/propidium iodide (Annexin V-fITC/PI) apoptosis detection kit was procured from Wuhan antgene Biotechnology co., ltd. (Hubei, china). caspase-3, -8 and -9 activity assay kits were obtained from Beyotime institute of Biotechnology (jiangsu, china). all other chemicals were of standard analytical grade.
Cell culture. Human glioma u87-Mg cells were purchased from american type culture collection (atcc) (Manassas, Va, uSa) and grown in RPMI-1640 supplemented with 10% fBS and 100 U penicillin/streptomycin in 5% Co 2 at 37˚C. cells were passaged every three days and maintained at exponential growth to ~80% confluence for later experiments.
MTT cell proliferation assay. Briefly, cells were seeded at 5,000 cells/well into a 96-well plate and incubated overnight. after exposure to different concentrations of quinidine for 48 h, MTT solution (final concentration 0.5 mg/ml) was added to each well and the samples were incubated for another 4 h. Subsequently, the supernatant was removed and cells were dissolved in 150 µl DMSo. finally, absorbance at 570 nm was measured by using a 96-well microplate reader (thermo fisher Scientific, Inc., Waltham, MA, USA).
Annexin V-FITC/PI apoptosis assay. cells were double-stained by using an Annexin V-fITC/PI apoptosis detection kit. Briefly, cells were seeded at 5x10 6 cells per flask into cultured flasks and incubated overnight. After exposure to different concentrations of quinidine for 48 h, cells were harvested and washed with cold PBS twice, and resuspended in Annexin V binding buffer. then 5 µl of fitc-labeled annexin V and 5 µl of PI were added. Cells were gently oscillated and incubated for 15 min at room temperature in the dark. after addition of 200 µl binding buffer to each tube, cells were analyzed on a flow cytometer (Becton-Dickinson, franklin lakes, nj, uSa) within 1 h.
Caspase activity assay. the activities of caspase-3, -8 and -9 were determined using the activity assay kits. to evaluate the activity of caspase, cell lysates were prepared after treatment with different concentrations of quinidine. assays were performed on 96-well microtitre plates by incubating 10 µl protein of cell lysate per sample in 80 µl reaction buffer [1% NP-40, 20 mmol/l Tris-HCl (pH 7.5), 137 mmol/l Nad and 10% glycerol] containing 10 µl caspase substrate (ac-DeVD-pna for caspase-3, ac-ietD-pna for caspase-8, ac-leHD-pna for caspase-9) (2 mmol/l). Lysates were incubated at 37˚C for 4 h. Samples were measured with a microplate reader at an absorbance of 405 nm. the detail analysis procedure is described in the manufacturer's protocol.
Electrophysiological assay. Membrane currents were recorded using a whole-cell voltage clamp and borosilicate glass pipettes (outer diameter, 1.5 mm; direct current resistance, 3-6 MΩ) constructed using a two-step puller (P-97; Sutter Instrument, novato, ca, uSa). to investigate the voltage-gated K + currents, the pipette solution consisted of 140 mmol/l Kcl, 2.5 mmol/l Mgcl 2 , 10 mmol/l HePeS, 11 mmol/l eGTA and 5 mmol/l ATP, and the pH was adjusted to 7.2 (18) . the cells were bathed in an extracellular solution containing 135 mmol/l nacl, 5.4 mmol/l Kcl, 1.0 mmol/l Mgcl 2 , 0.33 mmol/l naH 2 Po 4 , 1.8 mmol/l cacl 2 , 10 mmol/l HePeS and 10 mmol/l D-glucose with 1 µmol/l ttX. the osmolarity was adjusted to 330 mosmol/l with sucrose, and the pH was adjusted to 7.4. Whole-cell patch clamp recordings were performed at room temperature using a patch clamp amplifier (Axon-200B; axon instruments, union city, ca, uSa) (19) . adjustments of capacitance and series resistance compensation were performed before the membrane currents were recorded. the membrane currents were filtered at 10 kHz (-3 dB), and the data were processed using Clampfit (Axon Instruments).
Microarray analysis of miRNAs gene expression. after treated with 100 µmol/l quinidine for 48 h, cells were harvested in PBS, collected by centrifugation, and total RNA extracted using the mirneasy kit (Qiagen, Hilden, germany) according to manufacturer's instructions. the experiment was repeated three times. Quantity and quality of rna was determined by absorbance (260 and 280 nm). lc Sciences (Houston, tX, uSa) performed microarray assay using 5 mg total rna which was size fractioned using a yM-100 Micron centrifugal filter (Millipore, Billerica, MA, USA) and the small rnas (<300 nt) isolated were 3'-extended with a poly(a) tail using poly(a) polymerase. three biological samples of rna were pooled and array was performed using quadruplicate internal repeats of pooled rna as previously described (12) . Data were analyzed by first subtracting the background and normalization of array was to statistical mean of all detectable transcripts. System related variation of data was corrected using loWeSS filter (locally-weighted regression) method (12) . Probes were single channel and detected signals greater than background plus thre times the standard deviation was derived.
Quantitative real-time PCR for miRNA expression. to confirm the mirna levels obtained from the microarray results, expression of mirnas was assessed using quantitative real-time PCR. Total cellular RNA was extracted from each of the experimental groups using Qiagen mirneasy rna purification system according to the manufacturer's instructions. Quantity and quality of rna was determined by absorbance (260 and 280 nm). reverse transcription was performed using gene specific primers. The sequences of the primer pairs are shown in Table Ⅰ . RNU6B was taken as an internal control. Quantitative real-time PCR was performed using Platinum SYBR-Green qPCR SuperMix-uDg (invitrogen life technologies carlsbad, ca, uSa). the reactions were carried out in a 96-well optical plate at 95˚C for 10 min and then amplified for 15 sec at 90˚C, followed by 30 sec at 60˚C for 40 cycles. the relative value of each mirna was calculated using the 2 -ΔΔct method, where ct is the number of cycles at which the application reaches a threshold, as determined by SDS software v1.2 (applied Biosystems, inc., foster city, ca, uSa). thermal denaturation was administered at the conclusion of the qPCR to determine the number of the products that were present in the reaction. each reverse transcription and qPCR assay was performed in triplicate.
Bioinformatic analysis of miRNAs. changes in expression of mirnas between the control and quinidine-treated groups were selected and their putative cellular target genes were predicted using targetScan (http://www.targetscan.org/). using gene ontology (go) (http://geneontology.org/) and Kyoto encyclopedia of genes and genomes (Kegg) analysis tool (http://www.genome.jp/kegg/), the target genes were categorized into the following two groups: apoptosis and cell proliferation.
Statistical analysis. Data were expressed as mean ± standard error (mean ± Se). Statistical significance was assessed by using paired Student's t-test. P<0.05 was considered to be statistically significant.
Results

Effect of quinidine on the proliferation of U87-MG cells.
to measure the effect of quinidine on the proliferation of u87-Mg cells, cells were treated with various concentrations of quinidine (12.5, 25, 50, 100, 200, 400 and 800 µmol/l) for 48 h, and Mtt assay was used to determine the number of the live cells remaining after the drug treatment. as shown in fig. 1a , quinidine significantly inhibited the cell proliferation of U87-MG cells in a dose-dependent manner (P<0.01). the value of ic 50 was calculated to be 58.96 µmol/l at 48 h.
Effect of quinidine on the apoptosis of U87-MG cells.
to determine whether the reduced cell viability by quinidine was related to apoptotic cell death, the effect of quinidine on apoptosis of U87-MG cells was studied by Annexin V-fITC/PI staining. as illustrated in fig. 1B , quinidine increased the percentage of apoptotic cells in a concentration-dependent manner, and the apoptotic rates of u87-Mg cells treated with 25, 50 and 100 µmol/l quinidine were 9.9, 29.6 and 53.1%, respectively. However, the effect of quinidine on necrosis was slight. at 100 µmol/l, quinidine only induced necrosis in ~2.5% of U87-MG cells, indicating that quinidine could induce apoptosis of u87-Mg cells without causing obvious necrosis.
apoptosis is always executed in a caspase-8-regulated plasma membrane extrinsic pathway and/or caspase-9-regulated mitochondrial intrinsic pathway (20) . to determine whether caspases were activated by quinidine, we examined the activities of caspase-3, -8 and -9 in quinidine-treated u87-Mg cells. as shown in fig. 1c , quinidine treatment (25, 50 and 100 µmol/l) resulted in a dose-dependent activation of the initiator caspases-9, and the executor caspase-3. additionally, activation of caspase-8 was also observed, but the activities of caspase-8 in quinidine-treated cells were not significantly different from that of control cells. These data implied that both mitochondrial and death receptor pathways were involved in the apoptotic process induced by quinidine in u87-Mg cells, and the mitochondrial pathway was the main mode.
Effect of quinidine on K
+ currents in U87-MG cells. to determine whether quinidine inhibited cell proliferation via fig. 2) . Briefly, the membrane potential was pre-hyperpolarized from -50 to -110 mV for 100 msec, depolarized from -50 to +60 mV (10 mV increment per step, duration 200 msec), and subsequently restored to the original depolarizing potential of -50 mV ( fig. 2a) . Depolarizing the voltage from -110 to -50 mV and maintaining the level of -50 mV for 100 msec inactivated transient K + currents, and a further depolarization voltage step from -50 to +60 mV evoked sustained . 2B ). the transient component ( fig. 2c ) was then visualized in isolation using point-by-point subtraction of the sustained component ( fig. 2B ) from the total outward current ( fig. 2a) . as illustrated in fig. 2D and e, quinidine shifted the current-voltage curves of transient and sustained K + currents downward at different depolarization potentials in a dose-dependent manner. Quinidine was more potent in suppressing sustained than transient K + currents. for instance, at the depolarizing voltage of +60 mV, the percentage inhibition by 100 µmol/l quinidine of transient and sustained K + currents were ~46.64 and 82.04%, respectively ( fig. 2D and e) .
Effect of quinidine on miRNA expression in U87-MG cells. to examine the mirnas involved in quinidine-induced cytotoxicity, total rna was extracted from u87-Mg cells treated with 100 µmol/l quinidine for 48 h. The µParaflo ® mirna microarray containing 2,042 mature human mirna probes was used to identify the cellular miRNA expression profiles. We found that the expression of specifc mirnas in quinidine-treated u87-Mg cells was signifcantly altered when compared to that in untreated (control) cells. the results of quinidine-regulated mirnas and their chromosomal locations are summarized in Table Ⅱ . of the 2,042 human mirnas tested, 11 mirnas were upregulated and 16 mirnas were downregulated in our experiment.
Based on previous published reports (22, 23) , we selected the following five miRNAs: the upregulated miR-149-3p, the downregulated mir-25-3p, mir-100-5p, mir-424-5p and mir-365a-3p and measured their expression levels by quantitative real-time PCR. After individual miRNA level in each sample was quantified and normalized to U6 expression, quantitative PCR data confirmed that the expressions of miR-149-3p and miR-424-5p were up-and downregulated significantly in the quinidine-treated U87-MG cells, respectively (P<0.05). although the expressions of mir-25-3p, mir-100-5p and mir-365a-3p were downregulated in microarray analysis, there were no statistically significant differences by real-time PCR analysis (fig. 3) . 
Prediction of potential targets for verified miRNAs.
Since the cellular functions of mirnas are directly mediated by controlling their target gene expression, we further analyzed the putative target genes of the mirnas and the functional relationship between the gene and anticancer properties using bioinformatic tools. first, the mirBase target database tool, Microcosm, revealed that 3,803 genes were potentially targeted by quinidine-specific mirnas. Moreover, since quinidine promotes the death of cancer cells through its anti-proliferative and pro-apoptotic activities, we selected genes with functions related to cell proliferation and apoptosis by using the go and Kegg analysis tool. consistent with the previous finding, the Go and KeGG analysis results showed that several target genes of the quinidine-responsive mirnas were functionally involved in anticancer pathways. these sets of genes are shown in fig. 4 .
Discussion
Since the pioneering study in lymphocytes by Decoursey et al in 1984 (24) , accumulating evidence has indicated that K + channels are relevant players in controlling cell proliferation and apoptosis of various tumor cells. of all K + channels, most studies are devoted to the impact of voltage-gated K + channels on proliferation and apoptosis of tumor cells (6, 25) . gliomas are the most common malignant brain tumors (26) , the levels of expression of Kv1.5 and 1.3 channel subtypes discriminated between various glioma groups, and a clear differential expression of Kv1.5 was observed according to malignancy grade (27) . We have shown previously that voltage-gated K + channels play roles in controlling cell proliferation and apoptosis of glioma cells (7). However, the underlying mechanisms remain poorly understood.
it was reported that voltage-gated K + channel blocker quinidine can inhibit the proliferation of human malignant mesothelioma cells and rat c6 glioma cells (8, 9) . However, the effects of quinidine on cell proliferation of human glioma cells and apoptosis of tumor cells have not been studied yet. in the present investigation, we found that quinidine could inhibit cell proliferation of human glioma u87-Mg cells in a dose-dependent manner. the increased apoptosis rate was also observed after incubation of the cells with certain concentration of quinidine, and the cells displayed typical apoptotic features, including chromatin condensation, indicating that quinidine could induce apoptosis in u87-Mg cells without causing conspicuous necrosis.
apoptosis was determined as activation of crucial caspases, such as initiator caspase-9 of intrinsic apoptosis pathway, initiator caspase-8 of extrinsic death receptor pathway and executioner caspase-3 (28) . We investigated whether one or both the caspase cascades were activated in quinidine-induced cell apoptosis, and found that caspase-9 activation was remarkably triggered in 100 µmol/l quinidine-treated cells through the mitochondria initiated caspase activation cascade.
Previous reports showed that pharmacological blockades of voltage-gated K + channels lead to cell proliferation inhibition (29) . fraser et al have reported that the ic 50 value of 4-aminopyridine in blocking voltage-gated K + channel currents of rat prostate cancer at-2 cells was 4±2 mmol/l (30), which was close to the ic 50 value of 4-aminopyridine in in hibiting cell proliferation of human glioma u87-Mg cells (7). our electrophysiological and pharmacological results proved that quinidine inhibited cell proliferation and apoptosis in the concentration range required to block voltage-gated K + channel currents, indicating that quinidine potentially inhibited cell proliferation and induced apoptosis by blocking voltage-gated K + channel activities. these data provided further support for the roles of voltage-gated K + channels in mediating cell proliferation and apoptosis.
Many mirnas have been reported to have an oncogenic or a tumor suppressor function and to be involved in tumor cell proliferation and apoptosis. However, little is known about the relationship between mirna expression and voltage-gated K + channels of tumor cells. the present study demonstrated that quinidine significantly altered expression of miRNAs in u87-Mg cells, including 11 upregulated and 16 downregulated mirnas. among the mirnas regulated by quinidine, some have been reported to be tumor suppressors. for instance, mir-149 and -204 function as tumor suppressors and trigger growth inhibition in human glioma cells (23, 31) . in addition, some mirnas have been reported to be oncogenic. for instance, knockdown or reduction of mir-10b led to glioma cell apoptosis, cell growth inhibition, and suppressed tumorigenicity (32) .
mir-149 is considered to be a potential tumor suppressor. Suppression of mir-149 has been demonstrated in various human cancers, such as colorectal cancer (33) and Hela cells (34). a recent mirna microarray study has shown that miR-149 was downregulated significantly in grade Ⅰ-Ⅳ astrocytomas, and overexpression of mir-149 inhibited glioblastoma cell proliferation and migration (35) . mir-424 is considered to be a potential oncogenic miRNA. It is significantly upregulated and involved in proliferation, migration and invasion, and chemoresistant in different human cancers (23, 36, 37) . noteworthy, there are no reports regarding the role of miR-424 in glioma cells. In the current study, we verified that mir-149-3p was upregulated in 100 µmol/l quinidine-treated cells by quantitative real-time PCR, whereas miR-424-5p was downregulated. This is the first report to indicate that the blockade of voltage-gated K + channels could affect the expression of mir-149-3p/mir-424-5p in tumor cells. the go and Kegg analysis results showed that the predicted target genes of mir-149-3p and mir-424-5p were functionally involved in cell proliferation and apoptosis process. future studies are needed to investigate the molecular mechanism of mir-149-3p and mir-424-5p in quinidine-induced anticancer effect.
in conclusion, the present study shows that voltage-gated K + channel blocker quinidine inhibits proliferation and induces apoptosis of u87-Mg glioma cells in a dose-dependent manner. A subset of human miRNAs reveals significant changes in expression in response to quinidine in the u87-Mg cell line. these results suggest that the antitumor effect of voltage-gated K + channel blocker quinidine in human glioma cells was mediated at least partly through regulating mirna expression, and provide new insight into the understanding of the molecular mechanisms of voltage-gated K + channels in mediating cell proliferation and apoptosis.
